Clinical Trials Logo

Negative Pressure Therapy clinical trials

View clinical trials related to Negative Pressure Therapy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05215730 Completed - Diabetic Foot Ulcer Clinical Trials

Comparison of Wound Healing Between MedCu Dressings With Copper Oxide and Negative Pressure Wound Therapy Treatment

Start date: July 7, 2021
Phase: N/A
Study type: Interventional

Randomized multisite two arms study in which one arm of patients will be treated with Negative Pressure Wound Therapy (NPWT) known also as Vacuum-assisted closure (VAC) treatment ("VAC Arm") and the second arm of patients will be treated with MedCu wound dressings with copper oxide (COD) ("Copper Arm"). The study goals are to compare the efficacy, cost and convenience between MedCu Wound Dressings with Copper Oxide (COD) and Negative Pressure Wound Therapy of diabetic foot wounds.

NCT ID: NCT03701152 Recruiting - Clinical trials for Negative Pressure Therapy

Comparison Between Two Different Protocols of Negative Pressure Therapy for Healing of Chronic Ulcers

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Negative Pressure Wound Therapy (NPWT), is a non invasive wound management tool which develops from negative pressure being applied to the wound. This promotes healing through the removal of infectious materials and enhancing granulation tissue formation. NPWT eases debridement as well as promoting healing of different types of wounds.

NCT ID: NCT02332993 Completed - Wound Clinical Trials

Nutritional Regulation of Wound Inflammation: Part III

FPP3
Start date: December 2014
Phase:
Study type: Observational

The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is available over the counter. ImmunAge (FPP) is an investigational drug, which means it has not been approved by the U. S. Food and Drug Administration (FDA). Approximately 30 subjects will participate in this study. 15 subjects will take the supplementation and 15 subjects to take no supplementation as the control. The